Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Achenbach

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
Nature Communications|March 22, 2022
Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectoriesBum Chul Kwon, Vibha Anand, Peter Achenbach, et al.
Nature Communications|March 16, 2016
Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized miceIsabelle Serr, Rainer W Fürst, Peter Achenbach, et al.
Diabetes|July 8, 2024
Autoantibodies to Truncated GAD(96-585) Antigen Stratify Risk of Early Insulin Requirement in Adult-Onset DiabetesSian L Grace, Kathleen M Gillespie, Claire L Williams, et al.
JAMA|January 29, 2020
Yield of a Public Health Screening of Children for Islet Autoantibodies in Bavaria, GermanyAnette-Gabriele Ziegler, Kerstin Kick, Ezio Bonifacio, et al.
Microbiome|April 27, 2016
Towards a functional hypothesis relating anti-islet cell autoimmunity to the dietary impact on microbial communities and butyrate productionDavid Endesfelder, Marion Engel, Austin G Davis-Richardson, et al.
Deutsches Arzteblatt International|November 8, 2022
SARS-CoV-2 Seroprevalence in Preschool and School-Age Children—Population Screening Findings From January 2020 to June 2022Raffael Ott, Peter Achenbach, Dominik A Ewald, et al.
JAMA|April 22, 2015
Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: the Pre-POINT randomized clinical trialEzio Bonifacio, Anette-G Ziegler, Georgeanna Klingensmith, et al.
Diabetes|March 10, 2025
A Comparative Analysis of the Sensitivity, Specificity, Concordance, and the 5-year Predictive Power of Diabetes-related Autoantibody AssaysJeffrey P Krischer, Sarah Muller, Lu You, et al.
Pediatric Diabetes|May 1, 2013
HLA-typing, clinical, and immunological characterization of youth with type 2 diabetes mellitus phenotype from the German/Austrian DPV databaseWendy L Awa, Bernard O Boehm, Silke Rosinger, et al.
Diabetes Care|March 7, 2014
GAD autoantibody affinity in adult patients with latent autoimmune diabetes, the study participants of a GAD65 vaccination trialStephanie Krause, Ulrike Landherr, Carl-David Agardh, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Nature Communications|March 22, 2022
Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectoriesBum Chul Kwon, Vibha Anand, Peter Achenbach, et al.
Nature Communications|March 16, 2016
Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized miceIsabelle Serr, Rainer W Fürst, Peter Achenbach, et al.
Diabetes|July 8, 2024
Autoantibodies to Truncated GAD(96-585) Antigen Stratify Risk of Early Insulin Requirement in Adult-Onset DiabetesSian L Grace, Kathleen M Gillespie, Claire L Williams, et al.
JAMA|January 29, 2020
Yield of a Public Health Screening of Children for Islet Autoantibodies in Bavaria, GermanyAnette-Gabriele Ziegler, Kerstin Kick, Ezio Bonifacio, et al.
Microbiome|April 27, 2016
Towards a functional hypothesis relating anti-islet cell autoimmunity to the dietary impact on microbial communities and butyrate productionDavid Endesfelder, Marion Engel, Austin G Davis-Richardson, et al.
Deutsches Arzteblatt International|November 8, 2022
SARS-CoV-2 Seroprevalence in Preschool and School-Age Children—Population Screening Findings From January 2020 to June 2022Raffael Ott, Peter Achenbach, Dominik A Ewald, et al.
JAMA|April 22, 2015
Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: the Pre-POINT randomized clinical trialEzio Bonifacio, Anette-G Ziegler, Georgeanna Klingensmith, et al.
Diabetes|March 10, 2025
A Comparative Analysis of the Sensitivity, Specificity, Concordance, and the 5-year Predictive Power of Diabetes-related Autoantibody AssaysJeffrey P Krischer, Sarah Muller, Lu You, et al.
Pediatric Diabetes|May 1, 2013
HLA-typing, clinical, and immunological characterization of youth with type 2 diabetes mellitus phenotype from the German/Austrian DPV databaseWendy L Awa, Bernard O Boehm, Silke Rosinger, et al.
Diabetes Care|March 7, 2014
GAD autoantibody affinity in adult patients with latent autoimmune diabetes, the study participants of a GAD65 vaccination trialStephanie Krause, Ulrike Landherr, Carl-David Agardh, et al.
Pageof 11